A detailed history of Israel Englander (Millennium Management LLC) transactions in Liva Nova PLC stock. As of the latest transaction made, Millennium Management LLC holds 71,700 shares of LIVN stock, worth $3.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71,700
Previous 30,500 135.08%
Holding current value
$3.41 Million
Previous $1.67 Million 125.12%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$43.38 - $54.59 $7.91 Million - $9.95 Million
182,256 Added 6.57%
2,958,237 $155 Million
Q2 2024

Aug 14, 2024

BUY
$51.76 - $64.15 $25.7 Million - $31.9 Million
497,020 Added 21.81%
2,775,981 $152 Million
Q1 2024

May 15, 2024

BUY
$48.6 - $57.12 $4.39 Million - $5.17 Million
90,426 Added 4.13%
2,278,961 $127 Million
Q4 2023

Feb 14, 2024

BUY
$43.45 - $53.66 $39.3 Million - $48.5 Million
903,840 Added 70.35%
2,188,535 $113 Million
Q2 2023

Aug 14, 2023

SELL
$42.28 - $51.43 $7.57 Million - $9.21 Million
-179,021 Reduced 12.23%
1,284,695 $66.1 Million
Q1 2023

May 15, 2023

BUY
$40.84 - $58.14 $30.3 Million - $43.2 Million
743,103 Added 103.12%
1,463,716 $63.8 Million
Q4 2022

Feb 14, 2023

SELL
$43.88 - $56.16 $13.8 Million - $17.7 Million
-315,512 Reduced 30.45%
720,613 $40 Million
Q3 2022

Nov 14, 2022

SELL
$48.37 - $66.5 $33 Million - $45.4 Million
-683,141 Reduced 39.73%
1,036,125 $52.6 Million
Q2 2022

Aug 15, 2022

BUY
$57.25 - $86.63 $15.2 Million - $23 Million
265,085 Added 18.23%
1,719,266 $107 Million
Q1 2022

May 16, 2022

BUY
$71.02 - $86.99 $3.81 Million - $4.66 Million
53,616 Added 3.83%
1,454,181 $119 Million
Q4 2021

Feb 14, 2022

BUY
$76.72 - $92.68 $170,702 - $206,213
2,225 Added 0.16%
1,400,565 $122 Million
Q3 2021

Nov 15, 2021

BUY
$76.02 - $88.62 $64 Million - $74.6 Million
842,305 Added 151.48%
1,398,340 $111 Million
Q2 2021

Aug 16, 2021

BUY
$73.44 - $87.01 $10.3 Million - $12.2 Million
140,381 Added 33.77%
556,035 $46.8 Million
Q1 2021

May 17, 2021

SELL
$62.9 - $82.41 $13.4 Million - $17.5 Million
-212,263 Reduced 33.8%
415,654 $30.6 Million
Q4 2020

Feb 16, 2021

BUY
$46.01 - $68.74 $23 Million - $34.4 Million
500,728 Added 393.69%
627,917 $41.6 Million
Q3 2020

Nov 16, 2020

SELL
$41.91 - $57.81 $1.18 Million - $1.63 Million
-28,273 Reduced 18.19%
127,189 $5.75 Million
Q2 2020

Aug 14, 2020

SELL
$39.87 - $56.9 $672,527 - $959,789
-16,868 Reduced 9.79%
155,462 $7.48 Million
Q1 2020

May 14, 2020

BUY
$34.22 - $76.49 $5.77 Million - $12.9 Million
168,746 Added 4708.31%
172,330 $7.8 Million
Q4 2019

Feb 14, 2020

SELL
$68.92 - $85.27 $21.7 Million - $26.8 Million
-314,807 Reduced 98.87%
3,584 $270,000
Q3 2019

Nov 14, 2019

BUY
$71.74 - $86.35 $18.3 Million - $22 Million
255,321 Added 404.82%
318,391 $23.5 Million
Q2 2019

Aug 15, 2019

BUY
$66.45 - $97.36 $3.3 Million - $4.84 Million
49,689 Added 371.34%
63,070 $4.54 Million
Q2 2019

Aug 14, 2019

SELL
$66.45 - $97.36 $25 Million - $36.6 Million
-375,891 Reduced 96.56%
13,381 $90,000
Q1 2019

May 14, 2019

BUY
$86.15 - $100.49 $31.1 Million - $36.3 Million
361,346 Added 1293.94%
389,272 $37.9 Million
Q4 2018

Feb 14, 2019

SELL
$84.14 - $125.42 $15.4 Million - $22.9 Million
-182,658 Reduced 86.74%
27,926 $2.55 Million
Q3 2018

Nov 14, 2018

SELL
$101.02 - $130.95 $53.2 Million - $69 Million
-527,073 Reduced 71.45%
210,584 $26.1 Million
Q2 2018

Aug 14, 2018

BUY
$81.75 - $105.37 $1.65 Million - $2.13 Million
20,179 Added 2.81%
737,657 $73.6 Million
Q1 2018

May 15, 2018

BUY
$79.95 - $89.74 $17.9 Million - $20.1 Million
224,035 Added 45.4%
717,478 $63.5 Million
Q4 2017

Feb 14, 2018

BUY
$71.8 - $88.21 $34.9 Million - $42.9 Million
485,840 Added 6390.11%
493,443 $39.4 Million
Q3 2017

Nov 14, 2017

BUY
$60.32 - $70.06 $458,612 - $532,666
7,603
7,603 $533,000

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.55B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.